Now that we understand how central to our health, having extra weight is, and the potential of improving health outcomes (heart disease, cancer, brain disease, kidney disease, liver disease etc) through the reduction of weight, the path is wide open for pharma and biotech companies to develop and market such drugs
Animal Model:Ovariectomized female mice of the SW strain [6] Dosage:62.5-2000 g Administration:Intravaginal injection Result:Stimulated a vaginal response similar to that caused by estrogen, resulting in a decrease in intravaginal tetrazolium, increased epithelial growth, and keratinization
Always screen your hypertensive patients for coexisting HFrEF(Heart Failure with reduced ejection fraction) to ensure you are prescribing a drug that helps, not harms
Some health issues patients have reported are severe and can lead to long-term complications